Nobuhiko Morimoto
Olympus Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nobuhiko Morimoto.
Cancer Cell | 2016
Shinichi Yachida; Laura D. Wood; Masami Suzuki; Erina Takai; Yasushi Totoki; Mamoru Kato; Claudio Luchini; Yasuhito Arai; Hiromi Nakamura; Natsuko Hama; Asmaa Elzawahry; Fumie Hosoda; Tomoki Shirota; Nobuhiko Morimoto; Kunio Hori; Jun Funazaki; Hikaru Tanaka; Chigusa Morizane; Takuji Okusaka; Satoshi Nara; Kazuaki Shimada; Nobuyoshi Hiraoka; Hirokazu Taniguchi; Ryota Higuchi; Minoru Oshima; Keiichi Okano; Seiko Hirono; Masamichi Mizuma; Koji Arihiro; Masakazu Yamamoto
Ampullary carcinomas are highly malignant neoplasms that can have either intestinal or pancreatobiliary differentiation. To characterize somatic alterations in ampullary carcinomas, we performed whole-exome sequencing and DNA copy-number analysis on 60 ampullary carcinomas resected from clinically well-characterized Japanese and American patients. We next selected 92 genes and performed targeted sequencing to validate significantly mutated genes in an additional 112 cancers. The prevalence of driver gene mutations in carcinomas with the intestinal phenotype is different from those with the pancreatobiliary phenotype. We identified a characteristic significantly mutated driver gene (ELF3) as well as previously known driver genes (TP53, KRAS, APC, and others). Functional studies demonstrated that ELF3 silencing in normal human epithelial cells enhances their motility and invasion.
Archive | 2014
Nobuhiko Morimoto
Archive | 2012
Nobuhiko Morimoto
Archive | 2006
Tetsuya Tanabe; Nobuhiko Morimoto
Archive | 2008
Tetsuya Tanabe; Nobuhiko Morimoto
Archive | 2008
Tetsuya Tanabe; Nobuhiko Morimoto
Archive | 2008
Tetsuya Tanabe; Nobuhiko Morimoto
Archive | 2002
Etsuo Shinohara; Takeo Takahashi; Nobuhiko Morimoto
Archive | 2013
Nobuhiko Morimoto
Archive | 2012
Nobuhiko Morimoto; Jun Funazaki